Plus: type 1 testing for newborns; noise exposure & diabetes; COVID-19 intubation
Can't see the images? View as webpage.
Facebook
Twitter
LinkedIn
To ensure that you never miss an issue, please whitelist us.

Aug. 15, 2020 : Issue #1055

TOP STORIES - Diabetes News & Research

Sugar Intake Linked to Fat Deposits Around the Heart

Noise Exposure Leads to Hyperglycemia

Diabetes and Intubation In COVID-19
Letter from the Editor

We have all talked to our patients about the need to reduce their sugar consumption, and although there are sugar substitutes and lots of evidence why sugar should be reduced, our consumption has continued to increase.

Our focus has always been on diabetes and weight gain as reasons to reduce sugar consumption, but now the AHA has taken a stand on reducing sugar for a totally different reason. Check out this week’s feature article from our University of Colorado PharmD candidate Fairuz Afram, and find out why the AHA has taken such a severe position.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief
Advertisement

TOP STORIES - Diabetes News and Research

Sugar Intake Linked to Fat Deposits Around the Heart
Increased pericardial adipose tissue volume leads to coronary heart disease, coronary artery calcification, atrial fibrillation, and reduced left ventricular function.
READ MORE
Noise Exposure Leads to Hyperglycemia
Stress hormones triggered by noise exposure affect insulin secretion and sensitivity.
READ MORE
Diabetes and Intubation In COVID-19
With a limited supply of mechanical ventilators, it is important to recognize patients with risk factors associated with the need for mechanical ventilation.
READ MORE

Did You Know? New Test Predicts Type 1 Diabetes in Newborns & Infants


Unlike type 2 diabetes, which has been linked to obesity and other lifestyle factors, type 1 diabetes cannot be prevented. Type 1 diabetes primarily affects those under the age of 25. Researchers say they have found a new, more accurate way to predict which babies will develop type 1 diabetes – potentially opening up the possibility of preventive treatment.

As outlined last week in a letter published by the journal Nature Medicine, the researchers say they have developed a "combined risk score" test that takes into account genetics, family history of diabetes, and biomarkers known to be linked to type 1 diabetes. When all those elements were considered together, the researchers report that they were able to "approach dramatically improved prediction of which children would develop type 1 diabetes," forecasting whether children under the age of two would end up with type 1 diabetes by the age of eight.

They have already followed 7800 children at a high risk of developing type 1 diabetes, from birth over nine years, for “The Environmental Determinants of Diabetes in the Young” (TEDDY) study. TEDDY study is now being put to a trial. The researchers say the same approach could potentially be used to predict whether newborns will develop other childhood diseases that are strongly linked to genetics, including celiac disease.

Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:

Fairuz Afram, PharmD Candidate, University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences

Zahra Hashemy, PharmD. Candidate, USF Taneja College of Pharmacy

Sameen Khan, Pharm.D. Candidate, USF College of Pharmacy 

Jessica Rogers, PharmD candidate, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences  

Stephen Rubano, PharmD. Candidate, USF Taneja College of Pharmacy

 About LaterPay: You will notice that some of our articles are now marked with a small credit card icon. This means you will be asked to pay a small fee to access the full article text (the cost is $0.39 per article, and you will be charged only after you have reached $5.00 in article views). The costs of producing a newsletter like Diabetes in Control have been increasing, which is why we are asking our readers to help support our ability to continue to bring you quality information about diabetes through charging a minimal price to read certain articles. Thank you for helping to support Diabetes in Control.
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
810 Bear Tavern Road Suite 102
Ewing, NJ, 08628
USA
www.diabetesincontrol.com
Facebook
Twitter
LinkedIn
©2020 HIPER, LLC. All rights reserved.

This email was sent by eHealthcare Solutions on behalf of:
Diabetes In Control
810 Bear Tavern Rd, Suite 102
Ewing, NJ, 08628, United States


DiabetesInControl.com | Contact Us
Subscription Center | Update Profile
Unsubscribe